Giving early-stage pancreatic cancer patients a CD40 immune-stimulating drug helped jumpstart a T cell attack to the notoriously stubborn tumor microenvironment before surgery and other treatments, according to a new study.
from Latest Science News -- ScienceDaily https://www.sciencedaily.com/releases/2021/04/210411114048.htm
from Latest Science News -- ScienceDaily https://www.sciencedaily.com/releases/2021/04/210411114048.htm
Immune-stimulating drug before surgery shows promise in early-stage pancreatic cancer
![Immune-stimulating drug before surgery shows promise in early-stage pancreatic cancer]()
Reviewed by cmakigo
on
April 12, 2021
Rating:
No comments:
Post a Comment